Montoya, Jose G.
Laessig, Katherine
Fazeli, Mir Sohail http://orcid.org/0000-0002-0369-3848
Siliman, Gaye
Yoon, Sophie S.
Drake-Shanahan, Elizabeth
Zhu, Chengyue
Akbary, Akbar
McLeod, Rima
Funding for this research was provided by:
Sanofi
Article History
Received: 21 December 2020
Accepted: 14 November 2021
First Online: 11 December 2021
Declarations
:
: This study was a literature review and required no ethics approval.
: Not applicable.
: Elizabeth Drake-Shanahan and Dr. Chengyue Zhu are currently employed by Sanofi. Dr. Akbar Akbary was employed by Sanofi at the time of this analysis but has since retired. Dr. Mir Sohail Fazeli (Evidinno Outcomes Research Inc.), Sophie Yoon, and Gaye Siliman were contracted by Doctor Evidence LLC, which was contracted by Sanofi to conduct the analysis and medical writing. Dr. Katherine Laessig is employed by Antios Therapeutics and previously served as a consultant to Sanofi and was compensated for this work. Dr. Rima McLeod prepared a literature review pertinent to use of spiramycin and in accordance with Sunshine laws was compensated for this by Sanofi. Dr. McLeod has studied and published results about a point-of-care test which she and colleagues found meets WHO ASSURED criteria for a perfect screening test [CitationRef removed–CitationRef removed]. This work is currently supported by a grant from The Thrasher Children’s Research Charity Foundation and a Research Seed Grant award from The University of Chicago Global Health Center, and is registered in Clinical Trials.gov. She currently is working without compensation with the FDA, with colleagues at LDBio and in Morocco, to introduce this test for use with FDA clearance and CLIA waiver in the USA. She, with colleagues and The University of Chicago, filed a patent application [CitationRef removed] to insure the high quality of this test is sustained. She is working, without compensation, with programs in Morocco [CitationRef removed], Colombia [CitationRef removed], and Panama [manuscripts in preparation] whose physicians and scientists are now, or will, utilize this testing at scale to help pregnant women and their families in these countries to prevent toxoplasmosis [CitationRef removed]. Dr. Montoya was an uncompensated consultant in contributing to the literature review. The remaining authors declare no conflicts of interest.